Try our Advanced Search for more refined results

December 19, 2016

In Re: Copaxone 775 Patent Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 20, 2016

    Teva Accuses Mylan, Others Of Infringing Copaxone Patent

    Teva Pharmaceutical Industries Ltd. on Monday accused Dr. Reddy's, Mylan, Sandoz and several other drugmakers in Delaware federal court of infringing one of its newer patents for the multiple sclerosis drug Copaxone, adding onto other lawsuits the drug companies are already engaged in over the blockbuster drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!